Policy papers and consultations

Sort by

Isotretinoin: call for information to be considered as part of an expert review

Call for information to support a review of isotretinoin, a treatment for severe acne. This review is being undertaken by the Medicines and Healthcare products Regulatory Agency with advice from the Commission on Human Medic…
- From: Medicines and Healthcare products Regulatory Agency
- Updated: 28 April 2023
- Data Protection and Privacy Information
  1. Introduction You can read the MHRA Privacy Notice to find out in…
Consultation on Acnecide face gel and face wash

We are seeking views on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets.
- From: Medicines and Healthcare products Regulatory Agency
- Updated: 23 September 2019
Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).
- From: Medicines and Healthcare products Regulatory Agency
- Updated: 5 July 2017

3 results